Table 1:

Baseline characteristics of patients with aSAH

Total (N = 392)Period 1 (n = 160)aPeriod 2 (n = 232)aP Value
Age (range) (yr)52 (44–61)52 (44–62)52 (46–61).9
Female (No.) (%)254 (65%)104 (65%)150 (65%).5
Tobacco (No.) (%)188 (48%)75 (47%)113 (49%).4
Chronic high blood pressure (No.) (%)168 (43%)76 (47%)92 (40%).1
Dyslipidemia (No.) (%)84 (21%)36 (22%)48 (21%).6
Diabetes mellitus (No.) (%)19 (5%)9 (6%)10 (4%).3
Modified Fisher grade
    1, 2 (No.) (%)73 (19%)34 (21%)39 (17%).3
    3 (No.) (%)103 (26%)37 (23%)66 (28%).2
    4 (No.) (%)216 (55%)89 (56%)127 (55%).8
WFNS
    I, II (No.) (%)270 (69%)105 (65%)165 (71%).2
    III (No.) (%)22 (6%)11 (7%)13 (6%).6
    IV (No.) (%)56 (14%)22 (14%)32 (14%)1
    V (No.) (%)44 (11%)22 (14%)22 (9%).2
  • a Period 1/period 2 (before/after January 2015) means chemical/balloon angioplasty as a first-line treatment of distal vasospasm.